334139 <common-name>N-[(e)-(3-bromophenyl)methylideneamino]-2-[[5-(4-bromophenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide</common-name> <description>N-[(e)-(3-bromophenyl)methylideneamino]-2-[[5-(4-bromophenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide is a chemical compound with the formula C23H17Br2N5OS. With an average molecular weight of 571.30 g/mol, N-[(e)-(3-bromophenyl)methylideneamino]-2-[[5-(4-bromophenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide is a heavy molecule.</description> <cas>303103-28-8</cas> <pubchem-id>6869886</pubchem-id> <chemical-formula>C23H17Br2N5OS</chemical-formula> <weight>571.3</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T15:44:01Z</created-at> <updated-at type="dateTime">2026-08-30T15:44:01Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1=CC=C(C=C1)N2C(=NN=C2SCC(=O)NN=CC3=CC(=CC=C3)Br)C4=CC=C(C=C4)Br</moldb-smiles> <moldb-formula>C23H17Br2N5OS</moldb-formula> <moldb-inchi>InChI=1S/C23H17Br2N5OS/c24-18-11-9-17(10-12-18)22-28-29-23(30(22)20-7-2-1-3-8-20)32-15-21(31)27-26-14-16-5-4-6-19(25)13-16/h1-14H,15H2,(H,27,31)/b26-14+</moldb-inchi> <moldb-inchikey>SLPIARLQVBHBPN-VULFUBBASA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">568.95206</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM330032</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[(e)-(3-bromophenyl)methylideneamino]-2-[[5-(4-bromophenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Triazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0284617</sync-id> <structure-inchikey>SLPIARLQVBHBPN-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000200000800000000800000000000000000000000000000000000000000000000402000004008000002084000000000000000000000004200000000000000000000000000000000000000020000000000200000004800010000200000000010000000000000080100000800400080100000000000000000000000001004000000000800000000000000094880000010100000000000000000000000000000000000000400000080000000000000000400000000000002c00000000000000004000000000000100004000000000000000002000000200000000000000000040000000001048000000000400000000010200000040000000004000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAgAAAAIwAAAIABBkBoAAAAAwMBBkBoAAAA AwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEHQCgAAAAD AwZAKAAAAAMEB0AoAAAAAwMHQCgAAAADAwZAKAAAAAMEEAAgAAAAAgYAYAAA AAICBgAoAAAAAwQIACgAAAADAgcAaAAAAAMCAQcAKAAAAAMDBgBoAAAAAwMB BkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZA aAAAAAMDASMAIAAAAAEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAA AAMEBkBoAAAAAwMBBkBoAAAAAwMBIwAgAAAAAQsAAWgMAQJoDAIDaAwDBGgM BAVoDAMGIAYHaAwHCGgMCAloDAkKaAwKCwALDAAMDQANDigCDQ8gDxAgEBEo AhESIBITaAwTFGgMFBVoDBUWaAwWF2gMFBgABxkgGRpoDBobaAwbHGgMHB1o DB0eaAwcHwAFAGgMCgZoDBcSaAweGWgMQgQAAAAGAAUEAwIBBQgHBgoJBhMU FRYXEgYaGxwdHhkXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:36:03Z</structure-indexed-at> </compound>